Search PDMR transactions

Notifier
Name
Annica Brising
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Alexander Brising
Position
Business Development Director
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
EQL Pharma AB
LEI code
549300Q8B2D2AE8GCW21
Details of transaction
Type of financial instrument Name ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
Share EQL Pharma AB SE0005497732 Acquisition 1,437 Quantity 12.10 SEK 27/11/2018 SPOTLIGHT STOCK MARKET
Share EQL Pharma AB SE0005497732 Acquisition 2,100 Quantity 12.25 SEK 27/11/2018 SPOTLIGHT STOCK MARKET
Share EQL Pharma AB SE0005497732 Acquisition 1,500 Quantity 12.25 SEK 26/11/2018 SPOTLIGHT STOCK MARKET
Aggregation
Name ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
EQL Pharma AB SE0005497732 Acquisition 27/11/2018 SPOTLIGHT STOCK MARKET 3,537 (Quantity) 12.18905852 SEK
EQL Pharma AB SE0005497732 Acquisition 26/11/2018 SPOTLIGHT STOCK MARKET 1,500 (Quantity) 12.25 SEK
Total: 5,037
<< Back